FRD
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- P/E of 8.15 is very low
- Price/Book below 1.0
- Current price well below Graham Number of $31.6
- Intrinsic value based on growth is lower ($15.54)
Ref Growth rates
- Massive YoY and Q/Q revenue growth (~78%)
- Low operating margins suggest inability to scale profitably
Ref Historical trends
- Strong 5Y (+127.7%) and 1Y (+27.1%) returns
- Recent 6M decline of 13.4%
Ref Altman Z-Score, Piotroski F-Score
- Manageable Debt/Equity (0.68)
- Piotroski F-Score of 2/9 is a severe warning sign
Ref Yield, Payout
- Very low payout ratio (7.21%)
- Negligible yield (0.88%)
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for FRD and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
FRD
Friedman Industries, Incorporated
Primary
|
+127.7% | +62.8% | +27.1% | -13.4% | +2.4% | +4.9% |
|
ACNT
Ascent Industries Co.
Peer
|
+29.2% | +48.5% | +3.6% | +1.1% | -27.8% | -3.5% |
|
AMTX
Aemetis, Inc.
Peer
|
-88.1% | -17.0% | +44.0% | +6.0% | +50.7% | +63.6% |
|
AVD
American Vanguard Corporation
Peer
|
-83.2% | -83.3% | -26.0% | -37.0% | -33.7% | -19.0% |
|
BIOX
Bioceres Crop Solutions Corp.
Peer
|
-85.0% | -90.1% | -82.5% | -68.0% | -11.8% | -7.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Basic Materials Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
FRD
Friedman Industries, Incorporated
|
NEUTRAL | $128.73M | 8.15 | 11.6% | 2.7% | $18.1 | |
|
ACNT
Ascent Industries Co.
|
BEARISH | $119.97M | - | -6.2% | 1.2% | $12.79 | Compare |
|
AMTX
Aemetis, Inc.
|
BEARISH | $151.6M | - | -% | -39.0% | $2.29 | Compare |
|
AVD
American Vanguard Corporation
|
BEARISH | $99.64M | - | -40.8% | -21.1% | $3.5 | Compare |
|
BIOX
Bioceres Crop Solutions Corp.
|
BEARISH | $76.17M | - | -18.9% | -17.7% | $1.2 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-18 | CHHIBBAR GAURAV | Chief Operating Officer | Purchase | 400 | $6,776 |
| 2026-03-09 | TAYLOR MICHAEL J | Chief Executive Officer | Purchase | 500 | $9,000 |
| 2026-03-03 | TAYLOR MICHAEL J | Chief Executive Officer | Purchase | 400 | $7,200 |
| 2026-02-23 | TAYLOR MICHAEL J | Chief Executive Officer | Purchase | 100 | $1,800 |
| 2026-02-23 | TAYLOR MICHAEL J | Chief Executive Officer | Purchase | 100 | $1,800 |
| 2026-02-19 | CHHIBBAR GAURAV | Chief Operating Officer | Purchase | 1,000 | $18,350 |
| 2026-02-18 | TAYLOR MICHAEL J | Chief Executive Officer | Purchase | 600 | $11,250 |
| 2025-12-02 | TAYLOR MICHAEL J | Chief Executive Officer | Purchase | 500 | $9,370 |
| 2025-12-01 | SCOTT SANDRA KAY | Director | Purchase | 1,000 | $20,160 |
| 2025-11-24 | TAYLOR MICHAEL J | Chief Executive Officer | Purchase | 2,000 | $38,750 |
| 2025-10-31 | CHHIBBAR GAURAV | Chief Operating Officer | Stock Award | 50,000 | - |
Past News Coverage
Recent headlines mentioning FRD from our newsroom.